Last edition
News about "Sobi UK"
NICE Recommends Tryngolza for Familial Chylomicronaemia Syndrome
National Institute for Health and Care Excellence issues final draft guidance recommending Tryngolza as a treatment option for eligible adults with familial chylomicronaemia syndrome.
Sobi UK | 03/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members